P.I.-WORKS
P.I. Works, the leading provider of AI driven and automated mobile network management solutions, announced today that it has joined the O-RAN ALLIANCE, a global, operator-led consortium aimed at driving the evolution of RAN towards open, intelligent and interoperable networks.
Since its inception two years ago, the O-RAN ALLIANCE has rapidly grown to more than 230 members, comprising top-tier operators and contributors, including vendors, start-ups and academic institutions. Open RAN technology (O-RAN), which serves as the premise of the consortium, is expected to introduce programmable intelligence into the radio network, to enable AI-based policy making and optimization for near real-time and non-real-time network automation. Such architecture will accelerate the introduction of new AI-based optimization use cases and applications, while enabling forward compatibility through its modular architecture. According to the Dell’Oro Group, O-RAN technology is forecasted to account for 10% of the global RAN market by 2025, indicating a gradual yet steady shift towards the adoption of white box RAN solutions.
As a vendor-agnostic, customer-centric vendor, P.I. Works understands that adoption of O-RAN technology will provide operators with a wider selection of customizable network management solutions, reducing vendor lock-in and driving CapEx efficiency. The P.I. Works EVO Platform is well equipped to address these architectural requirements, offering cutting-edge AI- and automation-powered multi-vendor and multi-technology network management capabilities. Leveraging the platform, P.I. Works can utilize its standout expertise in network planning, optimization, performance management and configuration management to achieve new levels of service assurance.
Dr. Erol Hepsaydır, VP of Business Development & Strategy at P.I. Works, said: “As a leader in automated mobile network management, P.I. Works is ready to support mobile operators in their transition towards an O-RAN ecosystem, while addressing their requirements for uniform network quality. Leveraging transparent service monitoring and assurance capabilities, operators are able to achieve a clear and impartial view of the network across different vendors, technologies and layers, diagnose anomalies, and establish vendor accountability. P.I. Works’ scalable and automated management platform is globally field proven and can help mobile operators in delivering a seamless user experience.”
For more information, please contact us at www.piworks.net or send an email to marketing@piworks.net .
About P.I. Works
View source version on businesswire.com: https://www.businesswire.com/news/home/20201207005417/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting styrker kapaciteten med samarbejdsfirmaet Market One30.6.2025 01:12:00 CEST | Pressemeddelelse
Andersen Consulting fortsætter udvidelsen af sin globale platform gennem en samarbejdsaftale med Market One, et konsulentfirma med base i Argentina, der specialiserer sig i kommercielle end-to-end-løsninger. Market One har hovedkontor i Argentina og er et førende konsulentfirma med speciale i kommerciel transformation i alle processens faser. Firmaet blev stiftet i 2009 af partnerne Esteban Neville og Jerónimo Fernández Abeijón og har en praktisk, resultatorienteret tilgang til alle projekter – de følger kunderne fra strategi til udførelse. Ekspertisen spænder over strategisk rådgivning, kommerciel optimering, teknologiaktivering og indsigtsdrevet beslutningstagning. Med en dokumenteret erfaring fra over 1.200 projekter i mere end 20 lande arbejder Market One med nogle af de mest anerkendte brands i verden og hjælper dem med at styrke deres kommercielle kapacitet og opnå bæredygtig vækst. "Vi er født til at løse problemer, men det er måden, vi gør det på, der adskiller os fra andre," s
SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to
Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release
Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further
Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også
PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release
PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom